Remodeling of enhancers in high-grade epithelial dysplasia of gastric mucosa and its effect on expression of proliferation-related gene CD24
Monographic Reports|更新时间:2025-03-11
|
Remodeling of enhancers in high-grade epithelial dysplasia of gastric mucosa and its effect on expression of proliferation-related gene CD24
Journal of Army Medical UniversityVol. 47, Issue 5, Pages: 426-434(2025)
作者机构:
1.重庆大学医学院,重庆
2.重庆大学附属肿瘤医院肝胆胰肿瘤中心,重庆
3.陆军特色医学中心(第三军医大学大坪医院)消化内科,消化系统肿瘤精准防治重庆市重点实验室,重庆
4.重庆市中医院肿瘤科,重庆
作者简介:
基金信息:
the National Natural Science Foundation for Excellent Young Scientists of China(81822032);the Natural Science Foundation for Distinguished Young Scholars of Chongqing(CSTC2019JCYJJQX0027)
XUE R,PAN Y W,TAN Y T,et al.Remodeling of enhancers in high-grade epithelial dysplasia of gastric mucosa and its effect on expression of proliferation-related gene CD24[J].J Army Med Univ,2025,47(05):426-434.DOI:10.16016/j.2097-0927.202408113.
XUE R,PAN Y W,TAN Y T,et al.Remodeling of enhancers in high-grade epithelial dysplasia of gastric mucosa and its effect on expression of proliferation-related gene CD24[J].J Army Med Univ,2025,47(05):426-434.DOI:10.16016/j.2097-0927.202408113.DOI:
Remodeling of enhancers in high-grade epithelial dysplasia of gastric mucosa and its effect on expression of proliferation-related gene CD24
收集2022年6月至2023年6月来自陆军特色医学中心消化内科的14例正常胃黏膜组织(Nor组)、31例胃黏膜高级别上皮内瘤变组织(HGIN组)和17例胃癌(gastric cancer,GC)组织(GC组),利用染色质靶向捕获测序(cleavage under targets and tagmentation,CUT&Tag)技术捕获组蛋白H3K27ac修饰的增强子区域;联合多组学分析筛选HGIN组织特异的活性增强子及其潜在调控的基因;采用免疫组化染色观察目的基因在不同类型临床样本中的表达差异,并通过CRISPR-dCas9基因编辑技术沉默活性增强子,观察目的基因的表达水平,并验证潜在调控关系。
Objective To identify the enhancer profile marked by histone H3K27ac modification in high-grade intraepithelial neoplasia (HGIN) in order to reveal the novel regulatory mechanism of HGIN pathogensis. Methods Gastric tissue samples were collected from Department of Gastroenterology of Army Medical Center of PLA between June 2022 and June 2023
including 14 normal gastric tissues (Nor group)
31 HGIN tissues (HGIN group) and 17 gastric cancer tissues (GC group). Cleavage under targets and tagmentation (CUT
&
Tag) technique was employed to capture enhancer regions modified by histone H3K27ac. Multi-omics analysis was performed to identify HGIN-specific active enhancers and their potentially regulated genes. Immunohistochemical profiling was performed to assess differential expression of the gene of interest across clinically stratified specimens
combined with CRISPR-dCas9-mediated ablation of active enhancers to monitor the gene of interest transcriptional dynamics and validate enhancer-mediated regulatory mechanisms. Results Epigenomic sequencing obtained the data with excellent quality
and indicated that obvious remodeling was observed in H3K27ac enhancers in HGIN and GC groups (
P
<
0.05)
though no significant difference in the genome-wide distribution of H3K27ac modification among the 3 groups.Combining transcriptome data revealed that enhancer remodeling may up-regulate the expression of the proliferation-related target gene
CD24
in the HGIN tissue; while
inhibiting enhancer activity can notably reduce
CD24
expression level (
P
<
0.05). Immunohistochemical assay displayed a positive correlati
on between the expression levels of
CD24
and
Ki-67
(
P
<
0.001). Conclusion The remodeling of H3K27ac enhancer represents a significant epigenetic feature of the transformation from normal condition to HGIN. Remodeling of H3K27ac enhancer up-regulates
CD24
which may facilitate the abnormal proliferation of gastric epithelial cells.
关键词
Keywords
references
AJANI J A , D’AMICO T A , BENTREM D J , et al . Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology [J]. J Natl Compr Canc Netw , 2022 , 20 ( 2 ): 167 - 192 . DOI: 10.6004/jnccn.2022.0008 http://dx.doi.org/10.6004/jnccn.2022.0008 .
National Clinical Research Center for Digestive Disease (Shanghai) , National Early Gastrointestinal Center Prevention& Treatment Center Alliance , Helicobacter Pylori Group of Chinese Society of Gastroenterology from Chinese Medical Association , et al . Chinese consensus on management of gastric epithelial precancerous conditions and lesions (2020) [J]. Chin J Dig , 2020 , 40 ( 11 ): 731 - 741 . DOI: 10.3760/cma.j.cn311367-20200915-00554 http://dx.doi.org/10.3760/cma.j.cn311367-20200915-00554 .
YU Y Y , ZHU Z G . Interpretation of the 5th edition WHO classificaion and staging of tumors of digestive system: gastric tumors [J]. J Surg Concepts Pract , 2020 , 25 ( 3 ): 207 - 210 . DOI: 10.16139/j.1007-9610.2020.03.007 http://dx.doi.org/10.16139/j.1007-9610.2020.03.007 .
JEON J W , KIM S J , JANG J Y , et al . Clinical outcomes of endoscopic resection for low-grade dysplasia and high-grade dysplasia on gastric pretreatment biopsy: Korea ESD study group [J]. Gut Liver , 2021 , 15 ( 2 ): 225 - 231 . DOI: 10.5009/gnl19275 http://dx.doi.org/10.5009/gnl19275 .
SMYTH E C , NILSSON M , GRABSCH H I , et al . Gastric cancer [J]. Lancet , 2020 , 396 ( 10251 ): 635 - 648 . DOI: 10.1016/S0140-6736(20)31288-5 http://dx.doi.org/10.1016/S0140-6736(20)31288-5 .
Bureau of Medical Administration of National Health Commission of the People’s Republic of China . Standardiza-tion for diagnosis and treatment of gastric cancer (2022 edition) [J]. Chin J Dig Surg , 2022 , 21 ( 9 ): 1137 - 1164 . DOI: 10.3760/cma.j.cn115610-20220726-00432 http://dx.doi.org/10.3760/cma.j.cn115610-20220726-00432 .
LIU W K , WU L Y , YU B , et al . Reprogramming characteristics of H3K27ac-marked enhancer in gastric intestinal metaplasia and its transcriptional regulatory mechanism [J]. J Army Med Univ , 2023 , 45 ( 6 ): 500 - 509 . DOI: 10.16016/j.2097-0927.202210071 http://dx.doi.org/10.16016/j.2097-0927.202210071 .
WU L Y . Remodeling characteristics of H3K27me3 silencing in intestinal metaplasia of gastric mucosa and preliminary functional identification of ATOH1, a regulator of intestinal metaplasia [D]. Chongqing : Army Medical University , 2023 . DOI: 10.27001/d.cnki.gtjyu.2023.000311 http://dx.doi.org/10.27001/d.cnki.gtjyu.2023.000311 .
YAO J , CHEN J , LI L Y , et al . Epigenetic plasticity of enhancers in cancer [J]. Transcription , 2020 , 11 ( 1 ): 26 - 36 . DOI: 10.1080/21541264.2020.1713682 http://dx.doi.org/10.1080/21541264.2020.1713682 .
FURLONG E E M , LEVINE M . Developmental enhancers and chromosome topology [J]. Science , 2018 , 361 ( 6409 ): 1341 - 1345 . DOI: 10.1126/science.aau0320 http://dx.doi.org/10.1126/science.aau0320 .
SCHOENFELDER S , FRASER P . Long-range enhancer-promoter contacts in gene expression control [J]. Nat Rev Genet , 2019 , 20 ( 8 ): 437 - 455 . DOI: 10.1038/s41576-019-0128-0 http://dx.doi.org/10.1038/s41576-019-0128-0 .
CORCES M R , TREVINO A E , HAMILTON E G , et al . An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues [J]. Nat Methods , 2017 , 14 ( 10 ): 959 - 962 . DOI: 10.1038/nmeth.4396 http://dx.doi.org/10.1038/nmeth.4396 .
CORREA P . A human model of gastric carcinogenesis [J]. Cancer Res . 1988 Jul 1 ; 48 ( 13 ): 3554 - 3560 .
QIN B J , TAN Y T , CHU Z L , et al . Remodeling of histone H3K27me3-associated silencers upregulates PGK1 expression in gastric high-grade intraepithelial neoplasia [J]. J Army Med Univ , 2024 , 46 ( 6 ): 597 - 607 . DOI: 10.16016/j.2097-0927.202310001 http://dx.doi.org/10.16016/j.2097-0927.202310001 .
YANG Y , ZHU G M , YANG L , et al . Targeting CD24 as a novel immunotherapy for solid cancers [J]. Cell Commun Signal , 2023 , 21 ( 1 ): 312 . DOI: 10.1186/s12964-023-01315-w http://dx.doi.org/10.1186/s12964-023-01315-w .
KRISTIANSEN G , SAMMAR M , ALTEVOGT P . Tumour biological aspects of CD24, a mucin-like adhesion molecule [J]. J Mol Histol , 2004 , 35 ( 3 ): 255 - 262 . DOI: 10.1023/b: hijo.0000032357.16261.c5 http://dx.doi.org/10.1023/b:hijo.0000032357.16261.c5 .
ZHAO K , WU C F , LI X J , et al . From mechanism to therapy: the journey of CD24 in cancer [J]. Front Immunol , 2024 , 15 : 1401528 . DOI: 10.3389/fimmu.2024.1401528 http://dx.doi.org/10.3389/fimmu.2024.1401528 .
TARHRIZ V , BANDEHPOUR M , DASTMALCHI S , et al . Overview of CD24 as a new molecular marker in ovarian cancer [J]. J Cell Physiol , 2019 , 234 ( 3 ): 2134 - 2142 . DOI: 10.1002/jcp.27581 http://dx.doi.org/10.1002/jcp.27581 .
SAGIV E , ARBER N . The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy [J]. Expert Rev Gastroenterol Hepatol , 2008 , 2 ( 1 ): 125 - 133 . DOI: 10.1586/17474124.2.1.125 http://dx.doi.org/10.1586/17474124.2.1.125 .
SANO A , KATO H , SAKURAI S , et al . CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma [J]. Ann Surg Oncol , 2009 , 16 ( 2 ): 506 - 514 . DOI: 10.1245/s10434-008-0252-0 http://dx.doi.org/10.1245/s10434-008-0252-0 .
ATHANASSIADOU P , GRAPSA D , GONIDI M , et al . CD24 expression has a prognostic impact in breast carcinoma [J]. Pathol Res Pract , 2009 , 205 ( 8 ): 524 - 533 . DOI: 10.1016/j.prp.2009.01.008 http://dx.doi.org/10.1016/j.prp.2009.01.008 .
Diagnostic value of endoscopic LCPL sign for high-risk intestinal metaplasia in gastric mucosa
Effect of calumenin on metastasis and invasion of gastric cancer and prognosis of patients
Cancer-associated fibroblasts promote proliferation and drug resistance of gastric cancer organoids: a primary study
Remodeling characteristics of H3K27me3-marked silencers in gastric signet-ring cell carcinoma and its transcriptional regulatory function
Effective prevention, early diagnosis and precise treatment of gastric cancer
Related Author
ZHENG Xipeng
PAN Huilin
WU Linyu
HOU Yongying
LIU Qin
MA Qiang
QIN Xiuyuan
LIU Kaijun
Related Institution
First Clinical College of Chongqing Medical University
Department of Pathology, Army Medical Center of PLA/Daping Hospital of Third Military Medical University, Chongqing
Department of Gastroenterology, Chongqing Key Laboratory of Precise Prevention and Treatment of Digestive Malignancies
Department of Gastroenterology,Chongqing Key Laboratory of Precise Prevention and Treatment of Digestive Malignancies,Army Medical Center of PLA/Daping Hospital of Third Military Medical University
Department of General Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University)